UnitedHealth Group Incorporated (UNH)
NYSE: UNH · IEX Real-Time Price · USD
486.18
-5.05 (-1.03%)
At close: Apr 23, 2024, 4:00 PM
486.00
-0.18 (-0.04%)
After-hours: Apr 23, 2024, 7:58 PM EDT
Stock Price Forecast
The 21 analysts with 12-month price forecasts for UnitedHealth Group stock have an average target of 569.19, with a low estimate of 460 and a high estimate of 675. The average target predicts an increase of 17.07% from the current stock price of 486.18.
Target | Low | Average | Median | High |
---|---|---|---|---|
Price | $460 | $569.19 | $562 | $675 |
Change | -5.38% | +17.07% | +15.60% | +38.84% |
Analyst Ratings
The average analyst rating for UNH stock from 22 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 7 | 7 | 7 | 7 | 7 | 6 |
Buy | 14 | 13 | 13 | 13 | 14 | 12 |
Hold | 2 | 2 | 2 | 2 | 3 | 4 |
Sell | 0 | 1 | 1 | 1 | 1 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 23 | 23 | 23 | 23 | 25 | 22 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Deutsche Bank | Deutsche Bank | Strong Buy Maintains $545 → $562 | Strong Buy | Maintains | $545 → $562 | +15.60% | Apr 19, 2024 |
Truist Securities | Truist Securities | Strong Buy Reiterates $600 | Strong Buy | Reiterates | $600 | +23.41% | Apr 17, 2024 |
RBC Capital | RBC Capital | Buy Maintains $596 → $555 | Buy | Maintains | $596 → $555 | +14.16% | Apr 17, 2024 |
Barclays | Barclays | Buy Maintains $534 → $560 | Buy | Maintains | $534 → $560 | +15.18% | Apr 17, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $566 → $571 | Buy | Maintains | $566 → $571 | +17.45% | Apr 17, 2024 |
Financial Forecast
Revenue This Year
Increased by 8.97%
from 371.62B
Revenue Next Year
436.27B
from 404.96B
Increased by 7.73%
from 404.96B
EPS This Year
27.99
from 23.86
Increased by 17.31%
from 23.86
EPS Next Year
31.59
from 27.99
Increased by 12.87%
from 27.99
Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 242.16B | 257.14B | 287.60B | 324.16B | 371.62B | 404.96B | 436.27B | 472.40B | 512.43B | 529.35B |
Revenue Growth | 7.03% | 6.19% | 11.84% | 12.71% | 14.64% | 8.97% | 7.73% | 8.28% | 8.48% | 3.30% |
EPS | 14.33 | 16.03 | 18.08 | 21.18 | 23.86 | 27.99 | 31.59 | 35.73 | 41.51 | 45.40 |
EPS Growth | 17.56% | 11.86% | 12.79% | 17.15% | 12.65% | 17.31% | 12.87% | 13.09% | 16.18% | 9.38% |
No. Analysts | - | - | - | - | - | 30 | 30 | 16 | 3 | 2 |
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 424.4B | 460.5B | 506.9B | 547.0B | 550.3B |
Avg | 405.0B | 436.3B | 472.4B | 512.4B | 529.4B |
Low | 387.5B | 405.8B | 448.3B | 483.9B | 513.6B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 14.2% | 13.7% | 16.2% | 15.8% | 7.4% |
Avg | 9.0% | 7.7% | 8.3% | 8.5% | 3.3% |
Low | 4.3% | 0.2% | 2.8% | 2.4% | 0.2% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 29.59 | 33.44 | 38.15 | 43.52 | 47.20 |
Avg | 27.99 | 31.59 | 35.73 | 41.51 | 45.40 |
Low | 26.49 | 29.78 | 32.33 | 39.93 | 44.05 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 24.0% | 19.5% | 20.7% | 21.8% | 13.7% |
Avg | 17.3% | 12.9% | 13.1% | 16.2% | 9.4% |
Low | 11.0% | 6.4% | 2.3% | 11.8% | 6.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.